Cannabis Science Conference to debut in Providence, R.I., with renewed focus on analytical science, medical cannabis, cultivation and psychedelics
18 juil. 2023 16h43 HE
|
Cannabis Science Conference
PROVIDENCE, R.I., July 18, 2023 (GLOBE NEWSWIRE) -- Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation and...
Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company’s Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA’)
06 juil. 2023 08h42 HE
|
Incannex Healthcare
Highlights: Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial to assess the...
Cortexa Makes First Drug Order for Australian Commercial Market
04 juil. 2023 08h55 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, July 04, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF), a biotechnology company focused on the research,...
Momentum Events Celebrates Historic Conference, Psychedelic Science 2023
23 juin 2023 14h47 HE
|
Psychedelic Science 2023
DENVER, June 23, 2023 (GLOBE NEWSWIRE) -- Momentum Events, one of the nation’s leading event production companies with a specialization in producing conferences and trade shows focused on emerging...
MAPS Receives $5 Million Grant from the Steven & Alexandra Cohen Foundation
22 juin 2023 08h00 HE
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
SAN JOSE, Calif., June 22, 2023 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the Steven & Alexandra Cohen Foundation has awarded MAPS...
PharmAla Biotech Receives Export Permit to Ship GMP LaNeo MDMA to the University of Sydney
16 juin 2023 09h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, June 16, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:PMBHF, a biotechnology company focused on the research,...
Optimi Health To Supply MDMA For Therapist Experiential Training Program at Numinus, Supported by MAPS
15 juin 2023 09h40 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, June 15, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
PharmAla Awarded Research Grant by Ontario Centre for Innovation
09 juin 2023 13h18 HE
|
PharmAla Biotech
TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA)(OTC:PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel...
Clearmind Medicine to Host Virtual Investor Conference on Psychedelics for Obesity
09 juin 2023 09h30 HE
|
Clearmind Medicine Inc.
The conference will stream live on Monday, June 12, at 10:00 AM EST Tel Aviv, Israel / Vancouver, Canada, June 09, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE:...
Colorado Governor Jared Polis Named Opening Speaker for Psychedelic Science 2023
09 juin 2023 08h00 HE
|
Psychedelic Science 2023
DENVER, June 09, 2023 (GLOBE NEWSWIRE) -- Psychedelic Science 2023, the breakthrough psychedelic conference hosted by Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by...